Age-Period-Cohort Analysis of Primary Bone Cancer Incidence Rates in the United States (1976–2005)
暂无分享,去创建一个
F. Bray | S. Devesa | R. Troisi | T. Grotmol | O. Bruland | T. J. Jonasdottir | K. Anfinsen | K. P. Anfinsen
[1] B. Alman,et al. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets , 2010, Nature Reviews Cancer.
[2] L. Koniaris,et al. Ewing sarcoma demonstrates racial disparities in incidence‐related and sex‐related differences in outcome , 2009, Cancer.
[3] Lisa Mirabello,et al. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons , 2009, International journal of cancer.
[4] M. Russo,et al. Down‐regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells , 2009, Journal of cellular physiology.
[5] L. Koniaris,et al. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. , 2009, The Journal of bone and joint surgery. American volume.
[6] L. Mirabello,et al. Osteosarcoma incidence and survival rates from 1973 to 2004 , 2009, Cancer.
[7] K. S. Hall,et al. Synchronous and metachronous skeletal osteosarcomas: The Norwegian Radium Hospital experience , 2009, Acta oncologica.
[8] S. Ferrari,et al. High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions , 2008, Journal of surgical oncology.
[9] E. Itoi,et al. Sex steroid receptors expression and hormone‐induced cell proliferation in human osteosarcoma , 2008, Cancer science.
[10] J. Brooks,et al. Immunohistochemical Expression of Estrogen Receptors in Chondrosarcomas and Enchondromas , 2008, International journal of surgical pathology.
[11] A. Stewart,et al. Osteosarcoma, Chondrosarcoma, and Ewing's Sarcoma: National Cancer Data Base Report , 2007, Clinical orthopaedics and related research.
[12] S. Gapstur,et al. Cancer Epidemiology and Prevention, 3rd Edition , 2007 .
[13] R. Hoover,et al. Perinatal factors, growth and development, and osteosarcoma risk , 2006, British Journal of Cancer.
[14] S. Ferrari,et al. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] A. Cleton-Jansen,et al. Estrogen Signaling Is Active in Cartilaginous Tumors: Implications for Antiestrogen Therapy as Treatment Option of Metastasized or Irresectable Chondrosarcoma , 2005, Clinical Cancer Research.
[16] A. Cleton-Jansen,et al. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. , 2005, The Lancet. Oncology.
[17] William D Mosher,et al. Use of contraception and use of family planning services in the United States: 1982-2002. , 2004, Advance data.
[18] M. Alini,et al. Action of Estradiol on Epiphyseal Growth Plate Chondrocytes , 2004, Calcified Tissue International.
[19] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[20] T. Murray. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. , 1998, Survey of ophthalmology.
[21] Ø. Bruland,et al. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. , 1997, European journal of cancer.
[22] J. Madans,et al. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. , 1997, American journal of epidemiology.
[23] S. Tretli,et al. Lifestyle changes during adolescence and risk of breast cancer: an ecologic study of the effect of World War II in Norway , 1996, Cancer Causes & Control.
[24] H. Adami,et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. , 1996, Journal of the National Cancer Institute.
[25] H. B. Marsden,et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. , 1996, Journal of the National Cancer Institute.
[26] T. Fears,et al. Graphical presentation of trends in rates. , 1995, American journal of epidemiology.
[27] T. Holford. Analysing the temporal effects of age, period and cohort , 1992, Statistical methods in medical research.
[28] G. Thomas,et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.
[29] F. Sim,et al. Survival and management considerations in postirradiation osteosarcoma and Paget's osteosarcoma. , 1991, Clinical orthopaedics and related research.
[30] A. Polednak. Primary bone cancer incidence in black and white residents of New York state , 1985, Cancer.
[31] T R Holford,et al. The estimation of age, period and cohort effects for vital rates. , 1983, Biometrics.
[32] D. Isenberg,et al. Osteosarcoma complicating familial Paget's disease. , 1980, Postgraduate medical journal.
[33] P. Trott,et al. International Classification of Diseases for Oncology , 1977 .
[34] G. Ardran,et al. Radiographic features of bone in several strains of laboratory mice and of their tumours induced by bone-seeking radionuclides. , 1976, Journal of anatomy.
[35] C. Beauchamp. Ewing Sarcoma Demonstrates Racial Disparities in Incidence-related and Sex-related Differences in Outcome: An Analysis of 1631 Cases From the SEER Database, 1973-2005 , 2010 .
[36] G. Ottaviani,et al. The etiology of osteosarcoma. , 2009, Cancer treatment and research.
[37] J. Moppett,et al. Second malignancies in children: the usual suspects? , 2001, European journal of radiology.
[38] G COOPER,et al. Bone cancer. , 1951, Virginia medical monthly.